Spirox Announces Positive Clinical Study Results for LATERA Implant in Patients with Nasal Valve Collapse, a Major Cause of Nasal Obstruction

News The study showed that the device provides a significant reduction in nasal obstruction symptoms in patients with nasal valve collapse and that early improvements were maintained through one year. Contributed Author:  Spirox, Inc. Topics:  Implantables